Abstract
BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have